Flash Market News AI Explainer

Why Is Regeneron Pharmaceuticals Stock Plummeting Today? REGN -12.02% (May 18)

Analysis Date: May 18, 2026. Regeneron Pharmaceuticals (REGN) shares plunged -12.02% today in a sharp sell-off. Here's the reason for the Regeneron Pharmaceuticals share-price drop today — why is REGN stock down today?

Ticker
REGN
Company
Regeneron Pharmaceuticals
Direction
Down
% Change
-12.02%
Date
May 18, 2026

What happened

Regeneron Pharmaceuticals (NASDAQ: REGN) fell approximately 12% on May 18, 2026, amid a wave of analyst downgrades that shook investor confidence in the biopharmaceutical company.

  • Citigroup Downgrade: Citigroup lowered its rating on Regeneron, adopting a more cautious view on the stock's near-term prospects.
  • Leerink Partners Downgrade: Leerink Partners also downgraded REGN and reduced its analyst forecast range to $641, citing concerns about the company's forward outlook.
  • Market Reaction: The combination of two high-profile downgrades in close succession triggered broad selling pressure, sending shares down more than 12% in a single session.
  • Company Context: Regeneron is a major biopharmaceutical company known for blockbuster treatments including Dupixent (atopic dermatitis, asthma) and Eylea (eye conditions).

This content is for educational and informational purposes only and is not investment advice.

Sources

  1. Citigroup lowered its rating on Regeneron, reflecting a more cautious stance on the stock.
  2. Leerink Partners downgraded Regeneron and reduced its research forecast range to $641.

Frequently asked

Why is Regeneron Pharmaceuticals stock down today?

Regeneron Pharmaceuticals (REGN) shares plunged -12.02% on May 18, 2026. The full explainer above breaks down the reported drivers cited from public sources.

Why did REGN plummet today?

According to the cited sources, the move on May 18, 2026 was driven by the catalyst summarized in the explainer. See the Sources list below for primary references.

What caused Regeneron Pharmaceuticals stock to crash today?

Regeneron Pharmaceuticals (NASDAQ: REGN) fell approximately 12% on May 18, 2026, amid a wave of analyst downgrades that shook investor confidence in the biopharmaceutical company.

REGN stock drop reason today?

Regeneron Pharmaceuticals shares closed down -12.02% on May 18, 2026 — a drop of 12.02% from the prior close.

Is this investment advice?

No. Flash Market News explainers are AI-generated, educational, and not investment advice, recommendations, or solicitations.

AI-generated explainer from verified sources; not investment advice.

Recent explainers